Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02220309 · ClinicalTrials.gov registry record
Stanford RAD-AT Study (Research on Anxiety and Depression - Anhedonia Treatment)
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 167
- Enrollment target
NCT02220309: Completed study, sponsored by Stanford University.
NCT02220309 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 167 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02220309 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 167 participants
- Enrollment target
Study Summary
This research study is aimed at understanding behaviors and brain circuits that relate to anxiety and depression. Our goal is to learn which circuits of the brain are involved in anxiety and how these circuits might affect daily functioning. This study has recently added an additional treatment component: participants undergo a 12 week course of either Pramipexole medication or rTMS therapy (explained below). The ultimate goal of the study is to offer participants experiencing anxiety and depression a treatment that is alternative to ones that have failed them in the past, and to apply the knowledge we gain from investigating the brain circuits involved in anxiety and depression to help personalize treatments. We invite anyone who has recently experienced any symptoms of anxiety and/or depression to participate (no diagnosis is required to participate).
Primary Outcome
General demographics questionnaires, alcohol use questionnaire, substance use questionnaires, Mood and Anxiety Symptom Questionnaire, Penn State Worry Questionnaire, Health at Work Performance Questionnaire, WHO Quality of Life questionnaire, Satisfaction with Life Survey, Emotion Regulation Questionnaire, Brief COPE questionnaire, Early Life Stress questionnaire, Quick Inventory of Depressive Symptomatology, Beck Depression Inventory, PTSD Checklist - Civilian Version, Beck Anxiety Inventory, B
Interventions
- DRUG Pramipexole Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2013-08-11 |
| Est. Completion | 2025-04-02 |
What the finished NCT02220309 record still lists
NCT02220309 is an observational study that tracks outcomes without assigning an intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Pramipexole Oral Tablet is the first listed.
NCT02220309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02220309 about?
NCT02220309 is a clinical study titled "Stanford RAD-AT Study (Research on Anxiety and Depression - Anhedonia Treatment)". This research study is aimed at understanding behaviors and brain circuits that relate to anxiety and depression. Our goal is to learn which circuits of the brain are involved in anxiety and how these circuits might affect daily functioning. This study has recently added an additional treatment com...
What is the current status of trial NCT02220309?
This trial is currently completed. The enrollment target is 167 participants. The study started on 2013-08-11. Estimated completion is 2025-04-02.
What interventions are being tested in trial NCT02220309?
The interventions under investigation include: Pramipexole Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT02220309?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04248283 · 167 participants · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI